In our study, the rate of EMA and/or TTG antibody positivity was found to be 18.6% of all the patients; 12.6% (53 patients) were serology positive without CD, and 6% were T1DM patients with CD. This evidence concerns the gene TGM2 and type 1 diabetes mellitus.